0001214659-22-011325.txt : 20220920 0001214659-22-011325.hdr.sgml : 20220920 20220920163015 ACCESSION NUMBER: 0001214659-22-011325 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220919 FILED AS OF DATE: 20220920 DATE AS OF CHANGE: 20220920 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jackman Stephan CENTRAL INDEX KEY: 0001864257 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40483 FILM NUMBER: 221254029 MAIL ADDRESS: STREET 1: C/O ALZAMEND NEURO, INC. STREET 2: 3802 SPECTRUM BOULEVARD, SUITE 112C CITY: TAMPA STATE: FL ZIP: 33612 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Alzamend Neuro, Inc. CENTRAL INDEX KEY: 0001677077 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 811822909 STATE OF INCORPORATION: DE FISCAL YEAR END: 0430 BUSINESS ADDRESS: STREET 1: 3500 LENOX RD. NE STREET 2: SUITE 1500 CITY: ATLANTA STATE: GA ZIP: 30326 BUSINESS PHONE: 844-722-6333 MAIL ADDRESS: STREET 1: 3500 LENOX RD. NE STREET 2: SUITE 1500 CITY: ATLANTA STATE: GA ZIP: 30326 4 1 marketforms-57156.xml PRIMARY DOCUMENT X0306 4 2022-09-19 0001677077 Alzamend Neuro, Inc. ALZN 0001864257 Jackman Stephan 3500 LENOX RD NE, SUITE 1500 ATLANTA GA 30326 true true false false Chief Executive Officer Common Stock 2022-09-19 4 P false 8500 1.2252 A 8500 D The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $1.2252. The range of purchase prices on the transaction date was $1.225 to $1.23 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. /s/ Stephan Jackman 2022-09-20